抑制劑溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 產品編號 | 圖片 | 產品描述 | 分子式 | 加入購物車 | |
|---|---|---|---|---|---|
|
TAK-733，≥96% | C17H15F2IN4O4 | |||
|
|
|||||
|
LY-2584702 (free base)，99% | C21H19F4N7 | |||
|
|
|||||
|
LY-2584702 (tosylate salt)，98% | C28H27F4N7O3S | |||
|
|
|||||
|
MLN2480,泛Raf激酶抑制劑，≥98% | C17H12Cl2F3N7O2S | |||
|
|
|||||
|
Dabrafenib (GSK2118436)，98% | C23H20F3N5O2S2 | |||
|
|
|||||
|
Pimasertib (AS-703026)，96% | C15H15FIN3O3 | |||
|
|
|||||
|
LGX 818，99% | C22H27ClFN7O4S | |||
|
|
|||||
|
Necrosulfonamide，98% | C18H15N5O6S2 | |||
|
|
|||||
|
PLX7904，≥97% | C24H22F2N6O3S | |||
|
|
|||||
|
JNK-IN-8，99% | C29H29N7O2 | |||
|
|
|||||
|
XMD17-109，99% | C36H46N8O3 | |||
|
|
|||||
|
GDC-0994，98% | C21H18ClFN6O2 | |||
|
|
|||||
|
LJI308，99% | C21H18F2N2O2 | |||
|
|
|||||
|
APS-2-79 (hydrochloride)，98% | C23H22ClN3O3 | |||
|
|
|||||
|
TAK-715，99% | C24H21N3OS | |||
|
|
|||||
|
PD318088，99% | C16H13BrF3IN2O4 | |||
|
|
|||||
|
SB590885，98% | C27H27N5O2 | |||
|
|
|||||
|
PLURIPOTIN，98% | C27H25F3N8O2 | |||
|
|
|||||
|
AZD8330，98% | C16H17FIN3O4 | |||
|
|
|||||
